Biotech - Technical Analysis Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech - Technical Analysis

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Jibacoa who wrote (412)	6/12/2002 3:12:46 PM
From: Jibacoa	Read Replies (1) of 544

It looks like another not so good day for Biotechs today. Among the few staying on the black so far is GNTA, which is apparently been helped by the announcement that they are planning to buy back some 5 M shares.<g> That is less than 10% (there are 66.tM shares out), but the institutions reportedly hold 74%(128% of the 38.4M float)and the insiders hold 42%. As an added possible booster (or s.sqze.<g>)there are 12.8M shares short (33.3% of the float) GNTA also recently granted AVE marketing rights to Genasense in a deal that could be worth $870 M.<g> All of which make for a possible interesting situation.<g> At any rate, it seems GNTA has support at the 6.25 to 6.50 level and today there were good up-ticks at the 6.70 level with intra-day support at 6.85.<g> siliconinvestor.com Bernard

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next